Disuprazole
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171936This classification denotes a proton pump inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V81J4OO2OT. European Medicines Agency schedules Disuprazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06327MIG. Disuprazole generally arises in the molecular formula C16H17N3OS2. The term DISUPRAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, no. 4, 1987, list 27.) DISUPRAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule disuprazole under HS 29333999 and SITC 51574. As of Q4 2014, DISUPRAZOLE remains the US FDA Preferred Term for this commodity. Disuprazole bears US NLM identifiers UMLS ID C1880366 and NCI Concept Code C65441. SMILES: S(=O)(CC1NCCC(SCC)C1C)C1[NH]C2C(N1)CCCC2.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.